<p>The <i>in vitr</i>o release data show the release profile of tenofovir from the gel; the slope of the line represents the release rate of the product. The data shown represent the mean ± standard deviation of 13 replicates.</p
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
<p>The <i>in-vitro</i> release profile of simvastatin with and without the apatite coating showing c...
<p>Summary of model fitting parameters and drug release estimates of E<sub>2</sub> from the <i>in si...
1<p>Manually handled, gel expelled in trash, n = 2.</p>2<p>Unopened applicator, removed from foil pa...
<p>A: Standard curve of RFP in PBS. B: Drug release curve of RFP in PBS. C: The relationship between...
<p>The data are presented as the means ± STDEV (the standard deviation, n = 3).</p
Trials of a vaginal Tenofovir gel for pre-exposure prophylaxis (PrEP) for HIV have given conflicting...
Background: Trials of a vaginal Tenofovir gel for pre-exposure prophylaxis (PrEP) for HIV have given...
<p>Each data point represents mean ± SE of 5 measurements, except for the control (0%) and 0.45% dat...
<p>Standard conditions for gel, epithelial and stromal thicknesses. These are at different times in ...
<p>Hair TFV concentrations for each subject are shown for each dosing period. Each line represents d...
<p>The SRLS shows approximately linear release of lidocaine for more than the 7 d administration per...
<p><b>A</b>: Release profiles as quantified by the time evolution of the remaining mass percentage o...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
<p>Miltefosine release from selected lipid nanocapsule formulations in PBS pH 7.4 at 37°C over a 24 ...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
<p>The <i>in-vitro</i> release profile of simvastatin with and without the apatite coating showing c...
<p>Summary of model fitting parameters and drug release estimates of E<sub>2</sub> from the <i>in si...
1<p>Manually handled, gel expelled in trash, n = 2.</p>2<p>Unopened applicator, removed from foil pa...
<p>A: Standard curve of RFP in PBS. B: Drug release curve of RFP in PBS. C: The relationship between...
<p>The data are presented as the means ± STDEV (the standard deviation, n = 3).</p
Trials of a vaginal Tenofovir gel for pre-exposure prophylaxis (PrEP) for HIV have given conflicting...
Background: Trials of a vaginal Tenofovir gel for pre-exposure prophylaxis (PrEP) for HIV have given...
<p>Each data point represents mean ± SE of 5 measurements, except for the control (0%) and 0.45% dat...
<p>Standard conditions for gel, epithelial and stromal thicknesses. These are at different times in ...
<p>Hair TFV concentrations for each subject are shown for each dosing period. Each line represents d...
<p>The SRLS shows approximately linear release of lidocaine for more than the 7 d administration per...
<p><b>A</b>: Release profiles as quantified by the time evolution of the remaining mass percentage o...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
<p>Miltefosine release from selected lipid nanocapsule formulations in PBS pH 7.4 at 37°C over a 24 ...
ARV drug levels in CVF fall off rapidly following IVR removal (grey arrow) but are quantifiable for ...
<p>The <i>in-vitro</i> release profile of simvastatin with and without the apatite coating showing c...
<p>Summary of model fitting parameters and drug release estimates of E<sub>2</sub> from the <i>in si...